| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |